Veeva Systems (NYSE: VEEV) today announced the expansion of Veeva Vault QMS, adding new capabilities to manage medtech field ...

In a report released today, Kenneth Wong from Oppenheimer maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target of $230.00. The company’s shares closed yesterday at ...

Veeva Systems (VEEV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Craig ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Veeva reported quarterly earnings on Aug. 28, sending the stock higher. The company achieved 15% revenue growth over the prior year, spearheaded by 19% growth in recurring subscriptions. That ...

As a leading software company catering to the healthcare sector, Veeva Systems (NYSE: VEEV) has provided solid growth while operating in a defensive industry. The stock has had a good year ...

I upgraded Veeva to “buy” in my previous post as I believed that the company was starting to see an acceleration in the top and bottom lines, with the stock up 19% since. The company reported ...

Veeva is the leading provider of cloud-based software solutions tailored to the life sciences industry. It provides an ecosystem of products to address the operating challenges and regulatory ...

Shares of healthcare software provider Veeva Systems (NASDAQ:VEEV) jumped 9.1% in the morning session after the company reported second-quarter earnings results. Revenue and operating profit beat ...

Subscription services revenue jumped 19% year over year, totaling $561.3 million. Veeva Systems reported strong earnings, surpassing management's expectations across several key metrics.

Veeva Systems (NYSE:VEEV) added ~5% pre-market Thursday after the cloud-based software solution provider focused on healthcare reported better-than-expected Q2 FY25 results and set its Q3 and full ...